Companies / THERAtRAME
THERAtRAME
Company
THERAtRAME discovers and develops first-in-class small molecules targeting the tRNA epitranscriptomics for the benefit of cancer patients
THERAtRAME has 2 investors on file, among them Noshaq and Qbic. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on fileMore from Noshaq
186 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (23%), AI & Machine Learning (19%), Industrial & Manufacturing (13%).
More from Qbic
43 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (42%), AI & Machine Learning (20%), Industrial & Manufacturing (17%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get THERAtRAME and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Noshaq adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/theratrame.com/investors
# also
GET /v1/companies/theratrame.com
GET /v1/companies/theratrame.com/news